Subject Accession	Species	Race	Race Specify	Ethnicity	Strain	Gender	Age Event	Age Event Specify	Subject Age	Age Unit	Subject Phenotype	ARM Accession	ARM Name	Study Accession	Study Brief Title	Biosample Accession	Biosample Description	Biosample Name	Biosample Type	Biosample Subtype	Study Time Collected	Study Time Collected Unit	Study Time T0 Event	Study Time T0 Event Specify	Biosample Treatment	Planned Visit Accession	Planned Visit Name	Experiment Accession	Expsample Accession	Expsample Description	Expsample Result Schema	Expsample Treatement	Reagent Accession	Reagent Name	Reagent Reporter Name	File Info ID	File Detail	File Name	Original File Name
SUB119252	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661804			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717687		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119252	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661805			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717688		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119253	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		44	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661806			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717689		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119253	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		44	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661807			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717690		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661808			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717691		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119254	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661809			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717692		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661810			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717693		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119255	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661811			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717694		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661812			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717695		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119256	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		36	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661813			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717696		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661814			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717697		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119257	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM779	Study group 3 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661815			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717698		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119258	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		45	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661857			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717740		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119258	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		45	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661862			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717745		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119259	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661855			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717738		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119259	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		31	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661856			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717739		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119260	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		23	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661860			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717743		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119260	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		23	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661861			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717744		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119261	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		40	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661858			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717741		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119261	Homo sapiens	White		Hispanic or Latino		Female	Age at initial vaccine administration		40	Years	Healthy	ARM780	Study group 3 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661859			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717742		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661774			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717657		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119262	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		49	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661775			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717658		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661816			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717699		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119264	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		22	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661817			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717700		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119266	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661818			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717701		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119266	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661819			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717702		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661776			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717659		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119267	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661777			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717660		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661778			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717661		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119268	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		29	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661779			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717662		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119269	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661820			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717703		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119269	Homo sapiens	Black or African American		Not Hispanic or Latino		Male	Age at initial vaccine administration		27	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661821			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717704		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119273	Homo sapiens	White		Hispanic or Latino		Male	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661822			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717705		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119273	Homo sapiens	White		Hispanic or Latino		Male	Age at initial vaccine administration		25	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661823			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717706		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661780			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717663		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119274	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		23	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661781			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717664		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119276	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		30	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661824			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717707		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119276	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		30	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661825			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717708		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661782			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717665		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119277	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		32	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661783			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717666		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661784			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717667		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119278	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		39	Years	Healthy	ARM776	Study group 2 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661785			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717668		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		29	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661826			Serum		-7	Days	Time of initial vaccine administration			PV2338	Day -7	EXP11773	ES717709		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119279	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		29	Years	Healthy	ARM777	Study group 2 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661827			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717710		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		26	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661846			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717729		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		26	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661847			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717730		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119280	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		26	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661848			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717731		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119281	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661828			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717711		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119281	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661829			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717712		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119281	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661830			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717713		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119284	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		38	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661849			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717732		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119284	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		38	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661850			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717733		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119284	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		38	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661851			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717734		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119285	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		42	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661831			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717714		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119285	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		42	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661832			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717715		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119285	Homo sapiens	Asian		Not Hispanic or Latino		Female	Age at initial vaccine administration		42	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661833			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717716		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661834			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717717		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661835			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717718		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119286	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		30	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661836			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717719		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119287	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		41	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661837			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717720		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119287	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		41	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661838			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717721		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119287	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		41	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661839			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717722		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119289	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661840			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717723		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119289	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661841			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717724		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119289	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		40	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661842			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717725		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119290	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		37	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661843			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717726		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119290	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		37	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661844			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717727		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119290	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		37	Years	Healthy	ARM774	Study group 1 Pneunomax23	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661845			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717728		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119291	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		44	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661852			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717735		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119291	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		44	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661853			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717736		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119291	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		44	Years	Healthy	ARM775	Study group 1 Saline	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661854			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717737		OTHER	T1	ESR9773	Quest Pneumovax Virus Neutrilization		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661786			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717669		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661787			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717670		OTHER	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119292	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		24	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661788			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717671		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661789			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717672		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661790			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717673		OTHER	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119293	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		26	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661791			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717674		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661792			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717675		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661793			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717676		OTHER	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119294	Homo sapiens	White		Not Hispanic or Latino		Male	Age at initial vaccine administration		28	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661794			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717677		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661795			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717678		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661796			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717679		OTHER	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119295	Homo sapiens	White		Not Hispanic or Latino		Female	Age at initial vaccine administration		33	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661797			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717680		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661798			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717681		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661799			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717682		OTHER	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119296	Homo sapiens	Asian		Not Hispanic or Latino		Male	Age at initial vaccine administration		49	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661800			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717683		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661801			Serum		0	Days	Time of initial vaccine administration			PV2339	Day 0	EXP11773	ES717684		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661802			Serum		14	Days	Time of initial vaccine administration			PV2352	Day 14	EXP11773	ES717685		OTHER	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
SUB119297	Homo sapiens	Black or African American		Not Hispanic or Latino		Female	Age at initial vaccine administration		43	Years	Healthy	ARM773	Study group 1 2009-2010 Fluzone	SDY180	Systems scale interactive exploration reveals quantitative and qualitative differences in response to 2009-2010 Fluzone influenza vaccine and pneumococcal vaccine	BS661803			Serum		28	Days	Time of initial vaccine administration			PV2354	Day 28	EXP11773	ES717686		VIRUS NEUTRALIZATION	T1	ESR9770, ESR9771, ESR9772	Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/59/2007 HA, NA (H1N1), Recombinant (6:2) influenza A virus A/Puerto Rico/8/1934: A/Brisbane/10/2007 HA, NA (H3N2), Influenza B virus B/Brisbane/60/2008		344527	Virus neutralization result	Serology_by_Cohort.344527.xlsx	Serology_by_Cohort.xlsx
